Loading stockData sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Loading stockData sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Pharmaceutical preparations company · DE · FY ends Dec · -$5M FCF
$17.75
+$0.25 (+1.43%)
EOD Sep 18, 2026
Negative free cash flow of -$6M. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
$149M
▲ +886.2% YoY
Op. Margin
—
ROIC
-150.14%
▲ +2202.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$5M
▲ +50.2% YoY
Op. Cash Flow (TTM)
-$5M
▲ +50.2% YoY
Net Debt
-$6M
Net Cash Position
Cash & Equiv.
$6M
Continue Research
SourceComputed from the 10-Q filed 14 May 2026, covering the period ending 31 Mar 2026, as reported to the SEC. Data last refreshed 15 May 2026. How this is calculated.
Price from market data, last close as of 18 Sept 2026. Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.